Public Health - As enacted, adds as a disease for which a laboratory must test during a standard serological test of a pregnant woman hepatitis C antibody (anti-HCV) with automatic reflex to HCV RNA if anti-HCV is reactive, and makes certain other changes to the process of conducting required pregnancy serological tests. - Amends TCA Section 68-5-602.

HB 111 amends Tennessee's maternal health screening law to require standard blood tests during pregnancy to include hepatitis C antibody (anti-HCV) testing, with automatic follow-up testing for HCV RNA if the antibody test is reactive. This directly affects all pregnant women in Tennessee receiving routine prenatal care, as it adds hepatitis C screening to the existing mandatory tests for syphilis, rubella, and hepatitis B. The key provision mandates that laboratories performing these standard serological tests must automatically conduct the HCV RNA test when anti-HCV is positive, streamlining the detection of active hepatitis C infection. The bill aims to improve early identification of hepatitis C in pregnant individuals to support timely treatment and maternal health outcomes.